To fight insulin resistance, start with an individualized assessment and sustainable changes in eating, movement, sleep, and weight management when relevant. Studies in people with prediabetes show that lifestyle programs can support remission, including for some people without weight loss. The right testing and treatment depend on your health history, medicines, pregnancy status, and metabolic risk. 1 2
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What is insulin resistance, and why does it matter?
Insulin resistance means cells in the liver, muscle, and fat tissue do not respond as strongly to insulin's signal. Over time, the pancreas may release more insulin to keep glucose in range. This higher insulin level is called hyperinsulinemia, and blood glucose may still look normal early on. 3
How insulin normally helps regulate blood glucose
After you eat, carbohydrates are broken down into glucose. Insulin, a hormone made by the pancreas, helps move glucose from the bloodstream into cells for energy or storage. The liver also responds to insulin by reducing its glucose output between meals. 3
What reduced insulin sensitivity means
When insulin signaling is less effective, the body may compensate by making more insulin. This is not a personal failure or proof that someone ate the “wrong” food. Insulin sensitivity is shaped by many factors, including genetics, body-fat distribution, physical activity, sleep, inflammation, some medications, and health conditions. 3 6
How insulin resistance relates to prediabetes and type 2 diabetes
As the pancreas becomes less able to keep up with the body’s insulin needs, glucose can rise into the prediabetes range and later the diabetes range. Prediabetes is not inevitable progress toward diabetes, but it is an important signal to discuss prevention and monitoring with a clinician. 4 5
What can contribute to insulin resistance?
There is rarely one cause of insulin resistance. Family history and daily habits both matter, and a useful plan focuses on the factors that can be changed without blaming the person experiencing them. 3
- Higher body weight can raise risk for insulin resistance in some people, but people in smaller bodies can also have insulin resistance and prediabetes. 3
- Low physical activity, poor sleep, and some forms of chronic stress are associated with worse metabolic health. 3
- Polycystic ovary syndrome (PCOS), a history of gestational diabetes, and some medicines, including glucocorticoids, can change glucose regulation and deserve clinician-guided evaluation. 4 6
- Fatty liver disease and abnormal blood lipids can occur alongside insulin resistance, which is one reason a broader metabolic review can be useful. 3
If irregular periods, excess facial hair, acne, or fertility concerns are part of your picture, read our guide to a low-glycemic diet for PCOS and bring those symptoms to a licensed clinician. PCOS needs its own assessment; it should not be self-diagnosed from insulin-related symptoms alone. 4
How can I fight insulin resistance with sustainable daily habits?
The most evidence-based approach is not a crash diet. Sustainable routines that improve food quality, activity, and sleep can lower diabetes risk, and the best plan is one you can keep doing beyond the first 30 days. 5 7
Build meals around balance, not restriction
A practical starting pattern includes vegetables, beans, fruit, whole grains, nuts, and other fiber-rich foods; protein foods; and mostly minimally processed choices. This is not a requirement to avoid all carbohydrates. Pairing carbohydrate foods with protein, fiber, or unsaturated fat may make meals more filling and can support a steadier overall eating pattern. 7
For meal ideas and grocery-level planning, our prediabetes diet guide and Mediterranean diet guide for prediabetes can help you build a flexible pattern rather than follow a short-term cleanse. 7
Make movement regular and include resistance work
Physical activity improves how skeletal muscle uses glucose. Federal guidelines recommend at least 150 minutes per week of moderate-intensity aerobic activity, plus muscle-strengthening activity on 2 or more days each week for most adults, with adaptations for ability and health status. 8
Walking, cycling, swimming, body-weight work, and strength training can all count. If you are starting from little activity, a smaller and repeatable increase is more useful than trying to overhaul your schedule at once. Our guide to exercise and insulin resistance explains how to build from your current baseline. 8
Treat sleep and consistency as part of the plan
Sleep problems can make appetite, energy, and daily routines harder to manage. Rather than chasing perfect sleep, consider consistent wake times, a wind-down routine, and a clinician visit for loud snoring, gasping during sleep, or severe daytime sleepiness. These symptoms can point to sleep disorders that need separate care. 9
How do clinicians check for insulin resistance or related blood sugar changes?
There is no single routine test that confirms insulin resistance in every person. Three common tests—fasting plasma glucose, A1C, and the oral glucose tolerance test—help clinicians identify prediabetes or diabetes and decide what follow-up makes sense. 4
| Test | What it can show | Important limit |
|---|---|---|
| Fasting plasma glucose | Blood glucose after fasting; it can identify prediabetes or diabetes using established diagnostic cutoffs. 4 | One result may need confirmation unless symptoms and clear high glucose are present. 4 |
| Hemoglobin A1C | An estimate of average glucose exposure over roughly the prior 2–3 months. 4 | Some blood conditions, pregnancy, and other factors can affect interpretation. 4 |
| Oral glucose tolerance test | How the body handles a measured glucose drink over time; it can detect impaired glucose tolerance. 4 | It takes longer and is not needed for everyone. 4 |
| Fasting insulin or HOMA-IR | May be used in some research or specialty settings to estimate insulin resistance. 3 | They are not stand-alone diagnostic tests for insulin resistance in routine care. 3 |
Useful questions for a visit include: Should I have fasting glucose, A1C, or an oral glucose tolerance test? Could PCOS, prior gestational diabetes, sleep apnea, or a current medicine affect my results? Which blood pressure, cholesterol, liver, or kidney tests also matter for me? You can use our overview of normal blood sugar levels to understand common terms before your appointment. 4
When might weight management be part of improving insulin resistance?
Weight management can be one part of metabolic care for some people, especially when excess weight is linked with elevated risk. But prediabetes remission is a meaningful outcome on its own, and weight loss is not the only measure of improvement. 1 2
In the Diabetes Prevention Program, intensive lifestyle intervention reduced the incidence of type 2 diabetes more than placebo among adults with elevated risk. 5 In the PLIS trial analysis, researchers also examined how changes in insulin sensitivity and insulin secretion related to remission after lifestyle intervention. 2
More recently, Sandforth and colleagues reported that some participants with prediabetes achieved remission without weight loss, and remission was associated with lower later diabetes risk in that study. Individual results vary, and a study finding cannot predict what will happen for one person. 1
When might a clinician discuss medication for insulin-resistance-related weight concerns?
Medication can be appropriate for some people after lifestyle support, lab review, and a discussion of risks and goals. Medication is not required for everyone, and eligibility is individual—especially for people who are pregnant, breastfeeding, taking diabetes medicines, or have a history of low blood sugar. 4 10 11
Metformin and other options
Metformin is an FDA-approved medicine for type 2 diabetes and may be considered in selected adults with prediabetes at higher risk, alongside lifestyle intervention. Common side effects include nausea, diarrhea, and other gastrointestinal symptoms; kidney function and other health factors affect whether it is appropriate. 4 12
GLP-1-based medicines
GLP-1 receptor agonists are medicines that act on a gut-hormone pathway involved in appetite and glucose regulation. Semaglutide is the active ingredient in Ozempic and Wegovy. Tirzepatide, the active ingredient in Mounjaro and Zepbound, acts on both GIP and GLP-1 receptors. Their FDA-approved labeled uses differ by product and should not be assumed from an online article. 10 11
These medicines can cause nausea, vomiting, diarrhea, constipation, and abdominal pain. FDA labels also include important warnings and contraindications, including a contraindication for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. They are not used during pregnancy for weight management. 10 11
Why branded and compounded options are not interchangeable
FDA-approved products such as Wegovy, Ozempic, Zepbound, and Mounjaro have product-specific FDA review and labeling. Compounded semaglutide and compounded tirzepatide are not FDA-approved, are not generic versions of those brands, and do not have FDA-evaluated outcomes data for their compounded formulations. A clinician should review the specific medication, source, form, risks, and follow-up plan. 10 11 13
| Situation | A sensible next step | Key trade-off or caution |
|---|---|---|
| You have risk factors but no recent testing | Schedule a clinician visit for appropriate glucose testing and a broader metabolic review. 4 | Symptoms alone cannot confirm insulin resistance. 4 |
| You have prediabetes | Discuss a structured lifestyle program, follow-up testing, and whether metformin fits your risk profile. 4 5 | Progress is not measured by weight alone. 1 |
| You have weight-management needs and metabolic risk | Discuss nutrition, activity, sleep, and whether prescription weight management is appropriate. 10 11 | Medication can have side effects and contraindications. 10 11 |
| You are pregnant, breastfeeding, or trying to conceive | Seek prompt individualized guidance from your obstetric or diabetes clinician. 4 | Medication choices and glucose targets change in pregnancy. 4 |
| You use insulin or a medicine that can lower glucose | Ask before making major diet, exercise, or medication changes. 4 | Changes can raise the risk of hypoglycemia. 4 |
3-min quiz
Explore clinician-guided weight management
If weight-management needs are part of your insulin-resistance concerns, a Chia provider can review your health history and determine whether compounded semaglutide or compounded tirzepatide may be clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Medications are compounded by state-licensed US 503A pharmacies; compounded drugs are not FDA-approved.
How does insulin-resistance-related weight management work at Chia?
At Chia, weight-management care starts online with a health questionnaire and a licensed US provider’s review. No prescription is guaranteed. For eligible adults whose clinician determines medication may fit their broader weight-management plan, we offer compounded semaglutide and compounded tirzepatide, which are not FDA-approved, through state-licensed US 503A compounding pharmacies, with home delivery and portal messaging between visits.
Compounded semaglutide is available from Chia as an injection, with plans currently starting at $249 per month. Compounded tirzepatide is available as tablets from $249 per month or injection from $299 per month. Microdosing plans are available for both treatments where clinically appropriate, with dosing directed and adjusted by the treating provider.
| Chia treatment | Available form(s) | What the clinician reviews |
|---|---|---|
| Compounded semaglutide | Injection; plans currently start at $249/month. | Health history, weight-management goals, current medicines, contraindications, side effects, and follow-up needs. |
| Compounded tirzepatide | Tablets from $249/month; injection from $299/month. | The same clinical factors, plus which available form fits the patient’s situation and provider judgment. |
Neither option diagnoses insulin resistance or directly addresses every possible cause of it. We do not treat a scale number as the only outcome. A provider may recommend a different approach, additional testing, or care with your primary-care, endocrinology, or OB-GYN team instead. Compounded medications are not FDA-approved.
When should I seek medical care sooner?
Seek prompt medical guidance for new or worsening high-glucose symptoms or if you are pregnant and have glucose concerns. Same-day or urgent care may be needed for severe vomiting, dehydration, confusion, fainting, trouble breathing, or very high glucose readings, particularly if you have known diabetes. 4
- Make a timely appointment if you have increased thirst, frequent urination, unexplained weight change, blurred vision, recurrent infections, or a lab result in the prediabetes or diabetes range. These symptoms can have several causes and need proper evaluation. 4
- Talk with a clinician before changing food intake, activity, or medication if you take insulin, sulfonylureas, or other medicines that can cause low blood sugar. 4
- Pregnancy, breastfeeding, plans for pregnancy, PCOS, prior gestational diabetes, kidney disease, and a history of hypoglycemia all change the care conversation. 4
Frequently asked questions about fighting insulin resistance
A useful 30-day plan is realistic: build meals around vegetables or fruit, protein, fiber-rich carbohydrate foods, and minimally processed choices; repeat a few easy meals; and avoid extreme restriction. A registered dietitian can personalize the plan for culture, budget, diabetes medicines, pregnancy, or PCOS. 7
High insulin sensitivity means cells respond well to insulin, so the body may need less insulin to manage glucose. It is generally the opposite of insulin resistance, but it is not diagnosed from symptoms alone. 3
Some FDA-approved GLP-1-based medicines are prescribed for specific type 2 diabetes or chronic weight-management indications, depending on the product and patient. They are not a universal treatment for insulin resistance, and side effects, contraindications, pregnancy plans, and other medicines need review. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data. 10 11 13
A continuous glucose monitor can be essential for some people with diabetes, but it is not routinely required to diagnose insulin resistance. It may be useful in selected situations when a clinician can help interpret the data and prevent unnecessary food fear or overreaction to normal glucose changes. 4
3-min quiz
Start with an online clinical review
If you want help sorting through weight-management options alongside your metabolic goals, start an online visit with Chia. A licensed provider reviews your information and prescribes only where clinically appropriate; a prescription is never guaranteed. See current details for semaglutide and tirzepatide.
References
- 1.Sandforth A, Arreola EV, Hanson RL, et al. Prevention of type 2 diabetes through prediabetes remission without weight loss. Nature Medicine. 2025.
- 2.Sandforth A, von Schwartzenberg RJ, Arreola EV, et al. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS). The Lancet Diabetes & Endocrinology. 2023.
- 3.Beaupere C, Liboz A, Fève B, et al. Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance. International Journal of Molecular Sciences. 2021.
- 4.American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
- 5.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002.
- 6.DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009.
- 7.American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
- 8.U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. 2018.
- 9.St-Onge MP, Grandner MA, Brown D, et al. Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health. Circulation. 2016.
- 10.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2025.
- 11.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 12.U.S. Food and Drug Administration. Metformin hydrochloride prescribing information. 2024.
- 13.U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
